Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Norethisterone acetate |
Is a |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone adverse reaction |
Causative agent (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to norethisterone |
Causative agent (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone [endocrine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone [progestogen oral contraceptive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone enanthate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone enanthate 200mg/1mL oily injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone [malignancy] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone ac [malignancy] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethindrone 0.35mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only ethinyl estradiol 0.035 mg and norethisterone 0.5 mg/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl oestradiol + norethindrone acetate 20mcg/1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl estradiol + norethindrone acetate 30mcg/1.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mestranol + norethindrone 0.05mg/1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone enantate |
Is a |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oestradiol + norethindrone acetate 1mg/0.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mestranol 50 microgram and norethisterone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol + norethindrone acetate 0.62mg/2.7mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol + norethisterone acetate 1mg/0.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ethinylestradiol and norethisterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing mestranol and norethisterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Norethindrone measurement |
Component |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aranelle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 30 microgram and norethisterone acetate 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing estradiol and norethisterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinyl estradiol and norethisterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone 170micrograms/24hours / Estradiol 50micrograms/24hours patche |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing estradiol and norethisterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to norethisterone |
Causative agent (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Norethisterone 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Norethisterone 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mestranol 50 microgram and norethisterone 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mestranol 50 microgram and norethisterone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mestranol 50 microgram and norethisterone 1 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinyl estradiol 0.035 mg and norethisterone 0.5 mg/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinyl estradiol 0.035 mg and norethisterone 0.5 mg/1 each oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Norethisterone acetate |
Is modification of (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone enantate |
Is modification of (attribute) |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
Has precise active ingredient |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Norethisterone 5 mg oral tablet |
Has precise active ingredient |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet |
Has precise active ingredient |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet |
Has precise active ingredient |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ethinylestradiol and ferrous fumarate and norethisterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mestranol 50 microgram and norethisterone 1 mg oral tablet |
Has precise active ingredient |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
Has precise active ingredient |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ethinylestradiol and norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Norethisterone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing mestranol and norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Norethisterone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol- and norethisterone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing estradiol and norethisterone in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol and norethisterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and norethisterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only ethinylestradiol and ferrous fumarate and norethisterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mestranol and norethisterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Norethisterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only estradiol and norethisterone in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Norethisterone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Norethisterone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |